New Strategies in the Treatment of Multiple Myeloma

Clinical Cancer Research , Vol. 19, No. 13. , pp. 3337-3344, doi:10.1158/1078-0432.ccr-12-1881 Multiple myeloma is the second most common hematologic malignancy affecting terminally differentiated plasma cells.

http://www.citeulike.org/user/jrifon/article/12457264